HIMS & HERS HEALTH, INC.

(HIMS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Hims & Hers Health Names Yemi Okupe CFO; Chief Medical Officer Stepping Down to Join Board

01/19/2022 | 10:21am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. -6.33% 2090.92 Delayed Quote.-23.03%
EBAY INC. -1.91% 44.35 Delayed Quote.-32.05%
HIMS & HERS HEALTH, INC. -3.26% 3.415 Delayed Quote.-46.11%
PAYPAL HOLDINGS, INC. -3.30% 78.54 Delayed Quote.-56.95%
UBER TECHNOLOGIES, INC. -8.28% 21.845 Delayed Quote.-43.29%
All news about HIMS & HERS HEALTH, INC.
05/10Citigroup Adjusts Hims & Hers Health's Price Target to $6 from $9, Keeps Buy Rating
MT
05/09Hims & Hers Health Narrows Q1 Loss on Higher Revenue; Raises Full Year 2022 Revenue Gui..
MT
05/09TRANSCRIPT : Hims & Hers Health, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09HIMS & HERS HEALTH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
05/09Earnings Flash (HIMS) HIMS & HERS HEALTH Reports Q1 Revenue $101.3M, vs. Street Est of ..
MT
05/09Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and Raises Full Y..
BU
05/09Hims & Hers Health, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/09Hims & Hers Health, Inc. Revises Earnings Guidance for the Full Year 2022
CI
05/09Hims & Hers Health, Inc. Provides Earnings Guidance for the Second Quarter of 2022
CI
04/13Guggenheim Initiates Hims & Hers Health With Buy Rating, $10 Price Target
MT
More news
Analyst Recommendations on HIMS & HERS HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 423 M - -
Net income 2022 -60,9 M - -
Net cash 2022 32,4 M - -
P/E ratio 2022 -11,4x
Yield 2022 -
Capitalization 727 M 727 M -
EV / Sales 2022 1,64x
EV / Sales 2023 1,30x
Nbr of Employees 398
Free-Float 74,8%
Chart HIMS & HERS HEALTH, INC.
Duration : Period :
Hims & Hers Health, Inc. Technical Analysis Chart | HIMS | US4330001060 | MarketScreener
Technical analysis trends HIMS & HERS HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 3,53 $
Average target price 6,33 $
Spread / Average Target 79,4%
EPS Revisions
Managers and Directors
Andrew Dudum Chairman & Chief Executive Officer
Oluyemi Okupe Chief Financial Officer
Melissa Baird Chief Operating Officer
Alex Bard Independent Director
Delos M. Cosgrove Independent Director